Recently, it was demonstrated that knockdown of Fas specifically enhanced cell death induced by the EGFR tyrosine kinase inhibitor in EGFR-mutant lung cancer cells (10) and Fas signaling promotes tumor growth through the JNK and Jun pathway (22). This evidence concerns the gene FAS and lung cancer.